As per new guideline on pediatric gastroesophageal reflux, acid-suppression therapy in patients with typical reflux symptoms should be limited to 4-8 weeks. Acid suppression should be avoided for cough, wheezing or asthma in the absence of typical reflux symptoms. In infants, a trial of hypoallergenic formula or maternal elimination for breast fed infants is recommended before use of acid suppression. The guideline is published online June 28, 2018 in JAMA Otolaryngology-Head and Neck Surgery.